Ascletis Pharma Inc. 歌禮製藥有限公司

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Gu, Jiong 顧炯 INED 397 397
2 Hua, Lin 華林 INED 397 397
3 Wei, Yizhen 魏以楨 INED 397 397
4 Wu He, Judy Jingdao 吳何淨島 ED, VP 2,453 622 155 298 3,528
5 Wu, Jason Jinzi 吳勁梓 Ch, CEO, Fdr 38,529 16,606 63 298 55,496
Total 1,191 40,982 17,228 218 596 60,215

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,191 40,982 17,228 218 596 60,215 Report
2023-12-31 1,155 60,280 0 242 0 61,677 Report
2022-12-31 1,150 24,979 0 272 0 26,401 Report
2021-12-31 1,107 22,212 0 233 0 23,552 Report
2020-12-31 1,120 13,547 0 122 0 14,789 Report
2019-12-31 1,280 13,024 0 172 0 14,476 Report
2018-12-31 516 26,682 0 160 0 27,358 Report
Total 7,519 201,706 17,228 1,419 596 228,468

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top